Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

Combined EXENatide and DApagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycemic control in patients with type 2 diabetes mellitus treated with metformin – EXENDA , a 24 week, prospective, randomized, placebo‐controlled pilot trial

(2021) Jürgen Harreiter et al.   DIABETES OBESITY & METABOLISM

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity

(2021) Thomas A. Wadden et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

(2021) Melanie Davies et al.   LANCET

Once-Weekly Semaglutide in Adults with Overweight or Obesity

(2021) John P.H. Wilding et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

(2021) Domenica Rubino et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Weight Can’t Wait: A Guide to Discussing Obesity and Organizing Treatment in the Primary Care Setting

(2021) Christine Gallagher et al.   Obesity

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

(2021) Matthew J Page et al.   BMJ-British Medical Journal

GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings

(2021) Linan Zeng et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Obesity in adults: a clinical practice guideline

(2020) Sean Wharton et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses

(2020) Stefan Schandelmaier et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Benefits and Risks of Bariatric Surgery in Adults

(2020) David E. Arterburn et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cancer Risk Associated with Lorcaserin — The FDA’s Review of the CAMELLIA-TIMI 61 Trial

(2020) John Sharretts et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patient preferences for glucagon-like peptide-1 receptor–agonist treatment attributes

(2019) Vivian T Thieu et al.   Patient Preference and Adherence

Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis

(2018) Rohan Khera et al.   GASTROENTEROLOGY

Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis

(2018) Romina Brignardello-Petersen et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Progress and challenges in anti-obesity pharmacotherapy

(2018) Daniel H Bessesen et al.   Lancet Diabetes & Endocrinology

The GRADE Working Group clarifies the construct of certainty of evidence

(2017) Monica Hultcrantz et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Mechanisms, Pathophysiology, and Management of Obesity

(2017) Steven B. Heymsfield et al.   NEW ENGLAND JOURNAL OF MEDICINE

Resolve conflicting rankings of outcomes in network meta-analysis: Partial ordering of treatments

(2017) Gerta Rücker et al.   Research Synthesis Methods

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY

(2016) W. Timothy Garvey et al.   Endocrine Practice

Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events

(2016) Rohan Khera et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Management of obesity

(2016) George A Bray et al.   LANCET

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

(2016)   LANCET

Weight-loss intervention adherence and factors promoting adherence: a meta-analysis

(2016) Marla Rogers et al.   Patient Preference and Adherence

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

(2015) Brian Hutton et al.   ANNALS OF INTERNAL MEDICINE

Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)

(2014) Z. Skrivanek et al.   DIABETES OBESITY & METABOLISM

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

(2014) M. A. Puhan et al.   BMJ-British Medical Journal

A graphical tool for locating inconsistency in network meta-analyses

(2013) Ulrike Krahn et al.   BMC Medical Research Methodology

Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

(2013) P. Hollander et al.   DIABETES CARE

Quantifying the impact of between-study heterogeneity in multivariate meta-analyses

(2012) Dan Jackson et al.   STATISTICS IN MEDICINE

Attitudes about the safety and efficacy of bariatric surgery among patients with type 2 diabetes and a body mass index of 30–40 kg/m2

(2012) David B. Sarwer et al.   Surgery for Obesity and Related Diseases

Network meta-analysis, electrical networks and graph theory

(2012) Gerta Rücker   Research Synthesis Methods

Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes

(2011) R. R. Wing et al.   DIABETES CARE

Checking consistency in mixed treatment comparison meta-analysis

(2010) S. Dias et al.   STATISTICS IN MEDICINE